Piroxicam 0.5% Topical Gel is a semisolid formulation, dispensed through a pump mechanism for easy and precise application. This compounded medication is used for targeted treatment of conditions such as Osteoarthritis, Rheumatoid Arthritis, Tendinitis, Bursitis, and Gout, delivering active ingredients directly to the affected area in a gel-like consistency.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Piroxicam 0.5% Topical Gel is a semisolid formulation that is dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment or absorption of active ingredients in a gel-like consistency.
The active ingredient in this formulation is piroxicam, a nonsteroidal anti-inflammatory drug (NSAID) that works to reduce inflammation and pain associated with these conditions. By applying Piroxicam 0.5% Topical Gel directly to the affected area, patients can experience localized relief of symptoms.
It is important to note that this formulation should not be used on open wounds or on areas of skin that are broken or irritated. Additionally, patients should be aware that this formulation may cause skin irritation and should be used with caution. It is always recommended to test a small amount of the gel on a patch of skin before full application to ensure no adverse reaction occurs.
Additionally, prescribers should be aware that this formulation should not be used in combination with other topical medications, as this may increase the risk of skin irritation.
If you have any questions about Piroxicam 0.5% Topical Gel or its use in treating musculoskeletal conditions, please do not hesitate to reach out. It is our goal to provide comprehensive information to ensure the safe and appropriate use of this compounded formulation.
Piroxicam 0.5% Topical Gel is a semisolid formulation that is dispensed through a pump mechanism, allowing for easy and precise application on the skin. This nonsteroidal anti-inflammatory drug (NSAID) is primarily used for the targeted treatment of various musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, tendinitis, bursitis, and gout. It is crucial for patients to be aware that piroxicam may interact with other medications, including but not limited to anticoagulants, diuretics, and other NSAIDs. Therefore, it is highly recommended that patients inform their healthcare provider of all medications they are currently taking before starting the use of piroxicam.
Furthermore, piroxicam may increase the risk of gastrointestinal bleeding. As such, patients should be closely monitored for signs of bleeding while using this medication. It is also worth noting that piroxicam may cause skin irritation. Patients are advised to use the medication with caution and to immediately report any signs of skin irritation to their healthcare provider. If you have any questions or concerns about the use of Piroxicam 0.5% Topical Gel, please do not hesitate to reach out to your healthcare provider or pharmacist for further guidance.
Piroxicam 0.5% Topical Gel is a semisolid formulation of a nonsteroidal anti-inflammatory drug (NSAID) that is used to treat a variety of musculoskeletal conditions. These conditions include osteoarthritis, rheumatoid arthritis, tendinitis, bursitis, and gout. The gel works by blocking the production of certain chemicals in the body that cause inflammation and pain.
This topical gel is dispensed through a pump mechanism, which facilitates easy and precise application on the skin for targeted treatment. The active ingredients are absorbed through the skin into the underlying tissues, providing relief directly to the affected area. It is important to note that Piroxicam 0.5% Topical Gel should not be used on open wounds or on areas of the skin that are broken or irritated. Additionally, it is crucial to avoid contact with the eyes, nose, and mouth.
When using Piroxicam 0.5% Topical Gel, it is essential to follow the instructions provided by your healthcare provider. Typically, the gel should be applied to the affected area of the skin two to three times daily. It is important to wash your hands before and after applying the gel to prevent any potential irritation to other areas of the skin.
While Piroxicam 0.5% Topical Gel is generally well tolerated, some people may experience side effects such as skin irritation, redness, or burning. If you experience any of these side effects, it is important to contact your healthcare provider immediately.
If you have any questions about using Piroxicam 0.5% Topical Gel, please do not hesitate to reach out. We are here to help you find the best treatment for your condition.
Piroxicam 0.5% Topical Gel is a semisolid formulation of the non-steroidal anti-inflammatory drug (NSAID) Piroxicam. It is designed to be applied directly to the skin for targeted treatment.
This medication is dispensed through a pump mechanism, which allows for easy and precise application on the skin.
Piroxicam 0.5% Topical Gel has a gel-like consistency, which aids in its absorption when applied to the skin.
The gel-like consistency of Piroxicam 0.5% Topical Gel allows for the active ingredients to be absorbed directly into the skin, providing targeted treatment to the affected area.
It should be stored at room temperature, away from heat and direct light. Do not freeze. Keep out of the reach of children.
Common side effects may include skin irritation at the application site. If these persist or worsen, contact your healthcare provider immediately.
The frequency of application will depend on your medical condition and response to treatment. Always follow your healthcare provider's instructions.
Before starting any new medication, it is important to discuss with your healthcare provider. Some medications may interact with Piroxicam 0.5% Topical Gel, affecting its effectiveness or causing side effects.
If you miss a dose, apply it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up.
Before using this medication, pregnant or breastfeeding women should discuss the potential risks and benefits with their healthcare provider.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)